Literature DB >> 25435658

Pharmacology in peripheral arterial disease: what the interventional radiologist needs to know.

Gnaneswar Atturu1, Shervanthi Homer-Vanniasinkam1, David A Russell1.   

Abstract

Peripheral arterial disease (PAD) is a progressive disease with significant morbidity and mortality. Risk factor control, using diet and lifestyle modification, exercise, and pharmacological methods, improves symptoms and reduces associated cardiovascular events in these patients. Antiplatelet agents and anticoagulants may be used to reduce the incidence of acute events related to thrombosis. The armamentarium available for symptom relief and disease modification is discussed. Novel treatments such as therapeutic angiogenesis are in their evolutionary phase with promising preclinical data.

Entities:  

Keywords:  antiplatelet therapy; gene therapy; interventional radiology; peripheral arterial disease; pharmacotherapy; symptom relief

Year:  2014        PMID: 25435658      PMCID: PMC4232431          DOI: 10.1055/s-0034-1393969

Source DB:  PubMed          Journal:  Semin Intervent Radiol        ISSN: 0739-9529            Impact factor:   1.513


  103 in total

1.  Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).

Authors:  L Norgren; W R Hiatt; J A Dormandy; M R Nehler; K A Harris; F G R Fowkes
Journal:  J Vasc Surg       Date:  2007-01       Impact factor: 4.268

Review 2.  Oral naftidrofuryl. A review of its pharmacology and therapeutic use in the management of peripheral occlusive arterial disease.

Authors:  L B Barradell; R N Brogden
Journal:  Drugs Aging       Date:  1996-04       Impact factor: 3.923

Review 3.  Pre-emptive analgesia for chronic limb pain after amputation for peripheral vascular disease: a systematic review.

Authors:  Efthymios Ypsilantis; Tjun Y Tang
Journal:  Ann Vasc Surg       Date:  2010-11       Impact factor: 1.466

4.  A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee.

Authors: 
Journal:  Lancet       Date:  1996-11-16       Impact factor: 79.321

5.  Cardiovascular events associated with smoking cessation pharmacotherapies: a network meta-analysis.

Authors:  Edward J Mills; Kristian Thorlund; Shawn Eapen; Ping Wu; Judith J Prochaska
Journal:  Circulation       Date:  2013-12-09       Impact factor: 29.690

Review 6.  Systematic review of the efficacy of cilostazol, naftidrofuryl oxalate and pentoxifylline for the treatment of intermittent claudication.

Authors:  J W Stevens; E Simpson; S Harnan; H Squires; Y Meng; S Thomas; J Michaels; G Stansby
Journal:  Br J Surg       Date:  2012-10-03       Impact factor: 6.939

7.  Drug-eluting stenting followed by cilostazol treatment reduces late restenosis in patients with diabetes mellitus the DECLARE-DIABETES Trial (A Randomized Comparison of Triple Antiplatelet Therapy with Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Diabetic Patients).

Authors:  Seung-Whan Lee; Seong-Wook Park; Young-Hak Kim; Sung-Cheol Yun; Duk-Woo Park; Cheol Whan Lee; Myeong-Ki Hong; Hyun-Sook Kim; Jae-Ki Ko; Jae-Hyeong Park; Jae-Hwan Lee; Si Wan Choi; In-Whan Seong; Yoon Haeng Cho; Nae-Hee Lee; June Hong Kim; Kook-Jin Chun; Seung-Jung Park
Journal:  J Am Coll Cardiol       Date:  2008-03-25       Impact factor: 24.094

8.  Efficacy of cilostazol after endovascular therapy for femoropopliteal artery disease in patients with intermittent claudication.

Authors:  Yoshimitsu Soga; Hiroyoshi Yokoi; Tomohiro Kawasaki; Hitoshi Nakashima; Masanori Tsurugida; Yutaka Hikichi; Masakiyo Nobuyoshi
Journal:  J Am Coll Cardiol       Date:  2009-01-06       Impact factor: 24.094

Review 9.  Cilostazol for peripheral arterial disease.

Authors:  P Robless; D P Mikhailidis; G P Stansby
Journal:  Cochrane Database Syst Rev       Date:  2008-01-23

10.  Randomized trial of the effects of cholesterol-lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20,536 people with peripheral arterial disease and other high-risk conditions.

Authors: 
Journal:  J Vasc Surg       Date:  2007-04       Impact factor: 4.268

View more
  1 in total

1.  Peripheral arterial disease: Effects of ethanolic extracts of seed kernels of mango (Mangifera indica .L) on acute hind limb ischemia-reperfusion injury in diabetic rats.

Authors:  Muthuramalingam RamPravinKumar; Karthik Dhananjayan
Journal:  J Tradit Complement Med       Date:  2021-05-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.